FL

Forge Life Science Partners

Description

Forge Life Science Partners is an investment firm.

Investor Profile

Forge Life Science Partners has backed more than 5 startups, with 2 new investments in the last 12 months alone. The firm has led 1 rounds, about 20% of its total and boasts 2 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Series B, Series C rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Oncology, Product Research.

Stage Focus

  • Series A (40%)
  • Series B (20%)
  • Series C (20%)
  • Post Ipo Equity (20%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Oncology
  • Product Research
  • Pharmaceutical
  • Life Science
  • Therapeutics
  • Health Care
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Forge Life Science Partners frequently co-invest with?

Nextech Invest
Europe, Zurich, Switzerland, Zürich
Co-Investments: 2
Catalio Capital Management
North America, New York, United States, New York
Co-Investments: 1
Casdin Capital
North America, New York, United States, New York
Co-Investments: 2
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 2
Merck KGaA, Darmstadt, Germany
Europe, Hessen, Germany, Darmstadt
Co-Investments: 1
BioTrack Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Blackbird Ventures
Oceania, New South Wales, Australia, Sydney
Co-Investments: 1
Andreessen Horowitz
North America, California, United States, Menlo Park
Co-Investments: 2
CC
North America, New York, United States, New York
Co-Investments: 1
Blackstone Group
North America, New York, United States, New York
Co-Investments: 1

Which angels does Forge Life Science Partners often collaborate with?

NL
North America, Massachusetts, United States, Cambridge
Shared Deals: 1

What are some of recent deals done by Forge Life Science Partners?

SAB Biotherapeutics

Sioux Falls, South Dakota, United States

SAB Biotherapeutics is a clinical-stage biopharmaceutical development company.

BiotechnologyClinical TrialsTherapeutics
Post Ipo EquityJul 21, 2025
Amount Raised: $175,000,000
Aclaris Therapeutics

Malvern, Pennsylvania, United States

Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.

BiotechnologyPharmaceuticalTherapeutics
Post Ipo EquityNov 18, 2024
Amount Raised: $80,000,000
Idrx

Plymouth, Massachusetts, United States

Idrx is a clinical-stage biopharmaceutical company dedicated to transforming cancer treatment.

BiotechnologyLife ScienceOncologyProduct Research
Series BAug 7, 2024
Amount Raised: $120,000,000
OnCusp Therapeutics

New York, New York, United States

OnCusp Therapeutics is a biopharmaceutical company turning cutting-edge research assets into innovative oncology treatments.

BiotechnologyHealth CareOncologyPharmaceuticalProduct Research
Series AJan 4, 2024
Amount Raised: $100,000,000
Escient Pharmaceuticals

San Diego, California, United States

Escient Pharmaceuticals is a privately-held biotechnology company focusing on the advancement of G Protein-Coupled Receptor targeted drugs.

BiotechnologyMedicalPharmaceuticalTherapeutics
Series CNov 28, 2022
Amount Raised: $120,000,000
Idrx

Plymouth, Massachusetts, United States

Idrx is a clinical-stage biopharmaceutical company dedicated to transforming cancer treatment.

BiotechnologyLife ScienceOncologyProduct Research
Series AAug 2, 2022
Amount Raised: $122,000,000